Clinical Trial

High Flow Nasal Oxygen for Exacerbation COPD

Study acronym: HiCAP
Recruiting
View on ClinicalTrials.gov →
Summary
In this pilot study the feasibility of performing a larger trial to study the non-inferiority of High Flow Nasal Oxygen compared to non-invasive ventilation in patients with acute acidotic hypercapnic exacerbation of COPD wil be investigated
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-10; most recent amendment 2025-08-20.
Status change: Not Yet Recruiting → Recruiting 2024-05-14
Trial Details
NCT Number NCT06084117
Lead Sponsor Franciscus Gasthuis
Collaborators: Reinier de Graaf Groep, Haga Medisch Centrum, Ikazia Hospital, Rotterdam
Conditions Acute Exacerbation of COPD
Enrollment 40 participants
Start Date 2024-05-14
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-21